UB faculty members Glenna Bett and Randall Rasmusson are among
the latest wave of entrepreneurs flooding START-UP NY, making our
region the leader with at least 42 companies. Their company -
CytoCybernetics - is developing technology that would make
prescription drugs safer.
The National Cancer Institute awarded For-Robin, a UB spinoff
company, $2 million to continue developing a potential treatment
for breast and other types of cancer. Area leaders say the benefits
extend beyond the medical to the importance of these young
companies in growing WNY's life sciences economy.
UB engineers develop a unique nanotechnolgy that promises
simpler and more affordable sensing techniques. The applications
are far-ranging and could help detect diseases, chemical weapons or